Table 2.

Outcome of the innervated flaps.

Patient	Followup (months)	Complications	Muscle strength	DASH/LEFS	MSTS
1	42	Wound breakdown	M5	69	27
2	19	—	M5	80	30
3	Died of disease	—	—	—	—
4	(1)	Flap failure (necrosis at 1 month po), substituted with no innervated flap	—	—	—
5	15	Flap failure (necrosis at 5 days po), substituted with reinnervated lat. dorsi	M4	31(DASH)	25
6	17	Lymphoedema	M4	47	23
7	20	Lymphoedema + superficial infection	M4	31	30
8	20	—	M5	80	30
9	14	—	M4	52	27
10	14	—	M5	0 (DASH)	30
11	15	—	M4	14 (DASH)	13
12	24	Superficial infection at donor site	M5	57	30
13	24	—	M5	78	30
14	18	—	M5	73	26
15	6	—	M4	75	27
16	6	—	M5	80	30
17	8	—	M4	80	30
18	8	—	M4	65	26
19	12	—	M3	65	25
20	18	—	M5	80	30
21	20	—	—	—	—
22	23	—	—	—	—